2 research outputs found
AI-Friendly.com: Artificial Intelligence Made Friendly
AI-Friendly is a web application that allows to easily perform binary classification with a neural network. It is free and allows network customization, making it a useful tool for machine learning courses.Sociedad Argentina de Inform谩tica e Investigaci贸n Operativ
S铆ndrome de Sweet asociado a neoplasias Sweet's syndrome associated with neoplasms
El s铆ndrome de Sweet fue descrito en el a帽o 1964 por Robert Douglas Sweet, como una entidad a la cual denomin贸 dermatosis neutrof铆lica febril y aguda. Se caracteriza por cinco rasgos principales: 1) aparici贸n brusca de placas eritemato-dolorosas en cara, cuello y extremidades; 2) fiebre; 3) leucocitosis polimorfonuclear; 4) denso infiltrado d茅rmico a predominio neutrofilico; 5) r谩pida respuesta al tratamiento esteroideo. Se puede clasificar en cinco grupos: idiop谩tico, parainflamatorio, paraneopl谩sico, secundario a drogas y asociado a embarazo. En el 20% de los casos se asocia a enfermedades malignas, representando las hematol贸gicas el 85% y los tumores s贸lidos el 15% restante. Se presenta una serie de siete casos de s铆ndrome de Sweet asociado a neoplasias, diagnosticados durante el per铆odo 2002-2006, de los cuales seis correspondieron a enfermedades oncohematol贸gicas y el restante a tumores s贸lidos. Como comentario de dicha casu铆stica, se hace hincapi茅 en la importancia del diagn贸stico de este s铆ndrome, debido a que puede anunciar la reca铆da del tumor o la progresi贸n de la enfermedad de base. De esta manera, mediante el uso de m茅todos de diagn贸stico y tratamiento oportunos, se lograr铆a mejorar la calida de vida de estos pacientes. Tambi茅n debe tenerse en cuenta, que los pacientes oncol贸gicos reciben m煤ltiples medicaciones (factor estimulante de colonias), que pueden estar implicadas en la aparici贸n de esta entidad, debiendo ser las mismas descartadas como posibles causas.<br>Sweet's syndrome was described in 1964 by Robert Douglas Sweet, as an entity he named acute febrile neutrophilic dermatosis. It is characterized by five main features: 1) sudden appearance of erythematous and tender plaques on the face, neck and extremities; 2) fever; 3) polymorphonuclear leukocytes; 4) predominantly neutrophilic dense infiltrate in the dermis, and 5) rapid response to steroid therapy. Sweet's syndrome can be classified into five groups: idiopathic, parainflammatory, paraneoplastic, drug-induced, and pregnancy-related. Twenty percent of cases are associated with malignancies; 85% out of them involve hematologic alignancies and the remaining 15%, solid tumors. A series of seven cases of Sweet's syndrome associated with neoplasms which were diagnosed from 2002 to 2006 is presented. Six cases were related to oncohematologic diseases and one to solid tumors. These results highlight the importance of the diagnosis of the syndrome, since it may predict tumor relapse or underlying disease progression. The timely use of diagnostic and treatment methods may improve the quality of life of these patients. The fact that oncology patients take multiple medications (a colony-stimulating factor) which may be associated with the onset of this entity must also be considered in excluding possible causes